Cargando…
New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence
Nowadays, cardiac regeneration is an emerging topic in the cardiovascular field because of the compelling need for effective therapies for repairing or replacing cardiac tissue damaged by pathological or physiological conditions. Indeed, irreversible myocardial remodeling which follows acute myocard...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493790/ https://www.ncbi.nlm.nih.gov/pubmed/32096748 http://dx.doi.org/10.2174/1574888X15666200225124451 |
_version_ | 1784579188890533888 |
---|---|
author | Rurali, Erica Vinci, Maria Cristina Bassetti, Beatrice Barbagallo, Veronica Pompilio, Giulio Gambini, Elisa |
author_facet | Rurali, Erica Vinci, Maria Cristina Bassetti, Beatrice Barbagallo, Veronica Pompilio, Giulio Gambini, Elisa |
author_sort | Rurali, Erica |
collection | PubMed |
description | Nowadays, cardiac regeneration is an emerging topic in the cardiovascular field because of the compelling need for effective therapies for repairing or replacing cardiac tissue damaged by pathological or physiological conditions. Indeed, irreversible myocardial remodeling which follows acute myocardial infarction represents a serious burden of this century. In this context, a great improvement in pharmacological and interventional techniques is accompanied by a big challenge of cardiac regenerative medicine. In the last 20 years, several clinical trials tried to investigate the role of different types of stem cells in promoting cardiac repair. However, the promising results obtained in the preclinical trials have not yet been reproduced in patients. Thus, the development of novel strategies to improve stem cell efficiency became imperative. Here, an overview of the more recent cell types proposed for cardiac regeneration is presented, together with the most interesting approaches to enhance cell regenerative potential as well as cell-free approaches. |
format | Online Article Text |
id | pubmed-8493790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-84937902021-11-02 New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence Rurali, Erica Vinci, Maria Cristina Bassetti, Beatrice Barbagallo, Veronica Pompilio, Giulio Gambini, Elisa Curr Stem Cell Res Ther Article Nowadays, cardiac regeneration is an emerging topic in the cardiovascular field because of the compelling need for effective therapies for repairing or replacing cardiac tissue damaged by pathological or physiological conditions. Indeed, irreversible myocardial remodeling which follows acute myocardial infarction represents a serious burden of this century. In this context, a great improvement in pharmacological and interventional techniques is accompanied by a big challenge of cardiac regenerative medicine. In the last 20 years, several clinical trials tried to investigate the role of different types of stem cells in promoting cardiac repair. However, the promising results obtained in the preclinical trials have not yet been reproduced in patients. Thus, the development of novel strategies to improve stem cell efficiency became imperative. Here, an overview of the more recent cell types proposed for cardiac regeneration is presented, together with the most interesting approaches to enhance cell regenerative potential as well as cell-free approaches. Bentham Science Publishers 2020-11-10 2020-11-10 /pmc/articles/PMC8493790/ /pubmed/32096748 http://dx.doi.org/10.2174/1574888X15666200225124451 Text en © 2020 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Rurali, Erica Vinci, Maria Cristina Bassetti, Beatrice Barbagallo, Veronica Pompilio, Giulio Gambini, Elisa New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence |
title | New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence |
title_full | New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence |
title_fullStr | New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence |
title_full_unstemmed | New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence |
title_short | New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence |
title_sort | new strategies to enhance myocardial regeneration: expectations and challenges from preclinical evidence |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493790/ https://www.ncbi.nlm.nih.gov/pubmed/32096748 http://dx.doi.org/10.2174/1574888X15666200225124451 |
work_keys_str_mv | AT ruralierica newstrategiestoenhancemyocardialregenerationexpectationsandchallengesfrompreclinicalevidence AT vincimariacristina newstrategiestoenhancemyocardialregenerationexpectationsandchallengesfrompreclinicalevidence AT bassettibeatrice newstrategiestoenhancemyocardialregenerationexpectationsandchallengesfrompreclinicalevidence AT barbagalloveronica newstrategiestoenhancemyocardialregenerationexpectationsandchallengesfrompreclinicalevidence AT pompiliogiulio newstrategiestoenhancemyocardialregenerationexpectationsandchallengesfrompreclinicalevidence AT gambinielisa newstrategiestoenhancemyocardialregenerationexpectationsandchallengesfrompreclinicalevidence |